SKI-O-703

SKI-O-703 · Oscotec Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SKI-O-703, covering 2017-10-20 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies. [Phase 2]

See pricing